Transplant center directory

Established in 2012 and located in Memphis, Tennessee, the Methodist Healthcare Blood and Marrow Transplant Program is a collaborative effort between Methodist Healthcare and the University of Tennessee Health Science Center. The program provides transplantation for adults with conditions such as leukemia, lymphoma, multiple myeloma, bone marrow failure syndromes, and aplastic anemia. Transplants are performed using all donor types. This may entail using a person's own stem cells or cells from a donor. Donor cells may come from either conventional sources such as a matched sibling or a fully matched unrelated donor or from alternative sources such as a haplo-identical (half-match relative) donor or umbilical cord blood. The program offers inpatient and outpatient services and also provides extracorporeal photopheresis. The program is accredited by FACT and AABB and continually strives to achieve patient outcomes that exceed the national average.

This center has been performing allogeneic transplants since 2012 and has been an NMDP/Be The Match transplant center since July 2016.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 63 patients.

The actual 1-year survival of these patients is 67.9%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 54.7% and 77.0%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.